NIPH Clinical Trials Search

UMIN ID: UMIN000001510

Registered date:18/11/2008

A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiednon-small cell lung cancer
Date of first enrollment2008/11/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)A: paclitaxel 120mg/m2 + carboplatin AUC 3, day1 and day15, q4w, 4 course B: TS-1 80mg/m2 oral, day1 to 14, q3w, 1 year


Primary Outcome2-year relapse free survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum76years-old
GenderMale and Female
Include criteria
Exclude criteria1) apparent interstitial pneumonitis or pulmonary fibrosis 2) uncontroled pleural effusion or ascitis 3) multiple lung cancer 4) concomittant malignanct 5) past history of radiotherapy or chemotherapy 6) active infection or uncontroled complication 7) past history of severe allergic reaction 8) Pregnant or expecting woman 9) other conditions not suitable for this study

Related Information


public contact
Name Motoki Yano
Address Japan
Affiliation Nagoya City University Graduate school of Medical Sciences Department of Oncology, Immunology, and Surgery
scientific contact
Name Motoki Yano
Address 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya Japan
Affiliation Nagoya City University Hospital Department of thoracic Surgery